2024
DOI: 10.2174/1389557523666230915103121
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Nanobiotechnology for the Treatment of Non-Hodgkin’s Lymphoma

Shuxian Liu,
Minghao Xu,
Lei Zhong
et al.

Abstract: Lymphoma is the eighth most common type of cancer worldwide. Currently, lymphoma is mainly classified into two main groups: Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL), with NHL accounting for 80% to 90% of the cases. NHL is primarily divided into B, T, and natural killer (NK) cell lymphoma. Nanotechnology is developing rapidly and has made significant contributions to the field of medicine. This review summarizes the advancements of nanobiotechnology in recent years and its applications in the tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 114 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?